Reducing cardiovascular risk in adults facing food insecurity with financial incentives
Official title: Cardiovascular Risk Reduction for Adults With Food Insecurity Using Structured Incentives (CVD-FIT)
Run by State University of New York at Buffalo · NCT06818669 · Data updated 2026-11-12
This study is testing whether giving financial help and support for buying healthy foods can lower heart disease risk and improve the lives of African American adults who are struggling with food insecurity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | State University of New York at Buffalo Academic / other |
| Locations | 1 site (Buffalo, New York) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | June 30, 2030 |
| Study ends | June 30, 2031 |
| Registry record updated | February 6, 2026 |
| Trial ID | NCT06818669 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are African American adults aged 40 and older who are food insecure and at risk for cardiovascular diseases.
✕Probably not a fit
Patients with significant mental health issues or those with a life expectancy of less than 12 months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This intervention aims to evaluate the effectiveness and cost-efficiency of CVD-FIT, which combines monthly income supplementation, weekly incentives for purchasing healthy foods, and telephone-based education on cardiovascular disease (CVD) risk reduction. The study will involve 200 African American adults who are food insecure and at risk for CVD, randomized to receive either the CVD-FIT intervention or enhanced usual care. Participants will be monitored over 12 months to assess changes in their CVD risk and quality of life.
Why it matters
Potential benefit: If successful, this intervention could significantly lower cardiovascular disease risk among food-insecure individuals.
How similar studies have gone: While similar approaches have been explored, this specific intervention combining financial incentives and education is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * self-report as African American/non-Hispanic Black * screen positive for food insecurity over the past 12-months using a food insecurity risk tool developed through completion of the research team's current NIH funded R01 (R01MD013826) * at risk for CVD defined as age ≥40 years and having a clinical diagnosis of diabetes, or hypertension, or hyperlipidemia, or being overweight/obese (defined as a BMI\>25), or being a current smoker * able to communicate in English. Exclusion Criteria: * Mental confusion on interview suggesting significant dementia * Participation in other cardiovascular disease clinical trials * Alcohol or drug abuse/dependency based on screening using CAGE questionnaire * Active psychosis or acute mental disorder based on self-report * Life expectancy \<12 months.
Where it's running
-
University at Buffalo
Buffalo, New York, United States Recruiting
Study contacts
- Study coordinator: Rebekah J Walker, PhD
- Email: rbwalker@buffalo.edu
- Phone: 716-829-5741
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.